Drug Interaction Between Paracetamol and Warfarin "INPAWA2"


Phase 4 Results N/A

Summary of Purpose

The objective of this study is to investigate whether paracetamol, given at therapeutic doses (2g/day and 3 g/day), may potentiate the anticoagulant effect of warfarin.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 April 2010.

1 Mar 2007 12 Apr 2010 1 Nov 2008 1 Feb 2010 1 Feb 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics


Conditions See All


Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Screening
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available